Connection

Terry Day to Middle Aged

Back to Details
This is a "connection" page, showing publications Terry Day has written about Middle Aged.
Terry Day
Connection Strength
1.482
Middle Aged
  1. Hobnail variant of papillary thyroid carcinoma: a systematic review and meta-analysis. Endocrine. 2021 04; 72(1):27-39.
    View in: PubMed
    Score: 0.052
  2. Evaluation of a survivorship needs assessment planning tool for head and neck cancer survivor-caregiver dyads. J Cancer Surviv. 2019 02; 13(1):117-129.
    View in: PubMed
    Score: 0.046
  3. Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial. Clin Cancer Res. 2019 02 15; 25(4):1156-1164.
    View in: PubMed
    Score: 0.046
  4. Comparison of psychosocial factors over time among HPV+ oropharyngeal cancer and tobacco-related oral cavity cancer patients. Am J Otolaryngol. 2019 Jan - Feb; 40(1):40-45.
    View in: PubMed
    Score: 0.045
  5. Outcomes and prognostic factors for parotid acinic cell Carcinoma: A National Cancer Database study of 2362 cases. Oral Oncol. 2018 07; 82:53-60.
    View in: PubMed
    Score: 0.044
  6. Preoperative predictors of occult nodal disease in cT1N0 oral cavity squamous cell carcinoma: Review of 2623 cases. Head Neck. 2018 09; 40(9):1967-1976.
    View in: PubMed
    Score: 0.044
  7. Primary Surgery vs Radiotherapy for Early Stage Oral Cavity Cancer. Otolaryngol Head Neck Surg. 2018 04; 158(4):649-659.
    View in: PubMed
    Score: 0.043
  8. Predictors of contralateral-bilateral nodal disease in oropharyngeal cancer: A National Cancer Data Base Study. Head Neck. 2018 02; 40(2):338-348.
    View in: PubMed
    Score: 0.042
  9. Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer. Cancer. 2017 Dec 15; 123(24):4841-4850.
    View in: PubMed
    Score: 0.042
  10. Clinical features of ectomesenchymal chondromyxoid tumors: A systematic review of the literature. Oral Oncol. 2017 04; 67:192-197.
    View in: PubMed
    Score: 0.041
  11. Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancer. Cancer. 2017 Jul 15; 123(14):2651-2660.
    View in: PubMed
    Score: 0.041
  12. Effect of postoperative radiotherapy on survival for surgically managed pT3N0 and pT4aN0 laryngeal cancer: Analysis of the National Cancer Data Base. Cancer. 2017 Jun 15; 123(12):2248-2257.
    View in: PubMed
    Score: 0.040
  13. Double paddle ulnar perforator free flap in reconstruction of through-and-through and fistulous defects of the head and neck. Laryngoscope. 2017 06; 127(6):1302-1305.
    View in: PubMed
    Score: 0.040
  14. Risk Factors Associated With Unplanned Readmission in Patients Undergoing Parotid Cancer Surgery: A Study of the National Cancer Database. JAMA Otolaryngol Head Neck Surg. 2016 06 01; 142(6):544-50.
    View in: PubMed
    Score: 0.039
  15. Predictors of survival in parotid adenocarcinoma not otherwise specified: a National Cancer Database study of 3155 patients. Head Neck. 2016 08; 38(8):1208-12.
    View in: PubMed
    Score: 0.038
  16. Prognostic Factors in Myoepithelial Carcinoma of the Major Salivary Glands. Otolaryngol Head Neck Surg. 2016 06; 154(6):1047-53.
    View in: PubMed
    Score: 0.038
  17. Rapidly Growing Lateral Neck Mass. JAMA Otolaryngol Head Neck Surg. 2016 Feb; 142(2):185-6.
    View in: PubMed
    Score: 0.038
  18. Intraoperative goal-directed hemodynamic management in free tissue transfer for head and neck cancer. Head Neck. 2016 04; 38 Suppl 1:E1974-80.
    View in: PubMed
    Score: 0.038
  19. Lymphoepithelial carcinoma of the major salivary glands: Predictors of survival in a non-endemic region. Oral Oncol. 2016 Jan; 52:24-9.
    View in: PubMed
    Score: 0.037
  20. Predictors of Nodal Metastasis in Parotid Malignancies: A National Cancer Data Base Study of 22,653 Patients. Otolaryngol Head Neck Surg. 2016 Jan; 154(1):121-30.
    View in: PubMed
    Score: 0.037
  21. Initial symptoms in patients with HPV-positive and HPV-negative oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg. 2014 May; 140(5):441-7.
    View in: PubMed
    Score: 0.033
  22. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg. 2014 Apr; 140(4):331-7.
    View in: PubMed
    Score: 0.033
  23. The association between T-stage and clinical nodal metastasis In HPV-positive oropharyngeal cancer. Am J Otolaryngol. 2014 Jul-Aug; 35(4):463-8.
    View in: PubMed
    Score: 0.033
  24. Oral cancer preventive practices of South Carolina dentists and physicians. J Cancer Educ. 2010 Jun; 25(2):166-73.
    View in: PubMed
    Score: 0.025
  25. Head and neck cancer recurrence and mortality in nonselective cyclooxygenase inhibitor users. Arch Otolaryngol Head Neck Surg. 2007 Jan; 133(1):28-31.
    View in: PubMed
    Score: 0.020
  26. Endoscopic resection of sinonasal hemangiomas and hemangiopericytomas. ORL J Otorhinolaryngol Relat Spec. 2006; 68(2):69-72.
    View in: PubMed
    Score: 0.019
  27. The use of temporal polyethylene implant after temporalis myofascial flap transposition: clinical and radiographic results from its use in 21 patients. J Oral Maxillofac Surg. 2006 Jan; 64(1):12-22.
    View in: PubMed
    Score: 0.019
  28. Assessing oral cancer knowledge among dental students in South Carolina. J Am Dent Assoc. 2005 Mar; 136(3):373-8.
    View in: PubMed
    Score: 0.018
  29. Systematic review of neuroendocrine carcinomas of the oropharynx. Head Neck. 2022 07; 44(7):1725-1736.
    View in: PubMed
    Score: 0.014
  30. Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma. Cell Rep Med. 2021 10 19; 2(10):100426.
    View in: PubMed
    Score: 0.014
  31. Scapular free flap reconstruction of pharyngoesophageal defects. Clin Otolaryngol. 2021 09; 46(5):1110-1113.
    View in: PubMed
    Score: 0.014
  32. Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation. Otolaryngol Head Neck Surg. 2021 10; 165(4):536-549.
    View in: PubMed
    Score: 0.013
  33. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2020 12 01; 146(12):1109-1119.
    View in: PubMed
    Score: 0.013
  34. Free Flap Inset Techniques in Salvage Laryngopharyngectomy Repair: Impact on Fistula Formation and Function. Laryngoscope. 2021 03; 131(3):E875-E881.
    View in: PubMed
    Score: 0.013
  35. Validation of a Novel, Multidomain Head and Neck Cancer Appearance- and Function-Distress Patient-Reported Outcome Measure. Otolaryngol Head Neck Surg. 2020 11; 163(5):979-985.
    View in: PubMed
    Score: 0.013
  36. Evaluation of a novel telemedicine-based intervention to manage body image disturbance in head and neck cancer survivors. Psychooncology. 2020 12; 29(12):1988-1994.
    View in: PubMed
    Score: 0.013
  37. Development and Validation of Nomograms for Predicting Delayed Postoperative Radiotherapy Initiation in Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2020 05 01; 146(5):455-464.
    View in: PubMed
    Score: 0.013
  38. Association of Medicaid Expansion Under the Affordable Care Act With Stage at Diagnosis and Time to Treatment Initiation for Patients With Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2020 03 01; 146(3):247-255.
    View in: PubMed
    Score: 0.013
  39. Temporal Trajectory of Body Image Disturbance in Patients with Surgically Treated Head and Neck Cancer. Otolaryngol Head Neck Surg. 2020 03; 162(3):304-312.
    View in: PubMed
    Score: 0.012
  40. Prognostic factors associated with achieving total oral diet following osteocutaneous microvascular free tissue transfer reconstruction of the oral cavity. Oral Oncol. 2019 11; 98:1-7.
    View in: PubMed
    Score: 0.012
  41. Body Image Disturbance in Surgically Treated Head and Neck Cancer Patients: A Patient-Centered Approach. Otolaryngol Head Neck Surg. 2019 08; 161(2):278-287.
    View in: PubMed
    Score: 0.012
  42. Prognostic factors associated with achieving total oral diet after glossectomy with microvascular free tissue transfer reconstruction. Oral Oncol. 2019 05; 92:59-66.
    View in: PubMed
    Score: 0.012
  43. Factors associated with gastrostomy tube dependence following salvage total laryngectomy with microvascular free tissue transfer. Head Neck. 2019 04; 41(4):865-870.
    View in: PubMed
    Score: 0.011
  44. Prognostic Impact of High-Risk Pathologic Features in HPV-Related Oropharyngeal Squamous Cell Carcinoma and Tobacco Use. Otolaryngol Head Neck Surg. 2019 05; 160(5):855-861.
    View in: PubMed
    Score: 0.011
  45. Causal attributions and their impact on psychosocial functioning in head and neck cancer patient-caregiver dyads: a preliminary, longitudinal study. Qual Life Res. 2019 Apr; 28(4):1105-1109.
    View in: PubMed
    Score: 0.011
  46. Association of Care Processes With Timely, Equitable Postoperative Radiotherapy in Patients With Surgically Treated Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2018 12 01; 144(12):1105-1114.
    View in: PubMed
    Score: 0.011
  47. Racial and Ethnic Disparities in Travel for Head and Neck Cancer Treatment and the Impact of Travel Distance on Survival. Cancer. 2018 08 01; 124(15):3181-3191.
    View in: PubMed
    Score: 0.011
  48. Thirty-day readmission in patients undergoing head and neck microvascular reconstruction. Head Neck. 2018 07; 40(7):1366-1374.
    View in: PubMed
    Score: 0.011
  49. Extracapsular Dissection vs Superficial Parotidectomy of Benign Parotid Lesions: Surgical Outcomes and Cost-effectiveness Analysis. JAMA Otolaryngol Head Neck Surg. 2017 11 01; 143(11):1092-1097.
    View in: PubMed
    Score: 0.011
  50. Prognostic factors and occult nodal disease in mucoepidermoid carcinoma of the oral cavity and oropharynx: An analysis of the National Cancer Database. Oral Oncol. 2017 09; 72:174-178.
    View in: PubMed
    Score: 0.010
  51. Physical and emotional well-being and support in newly diagnosed head and neck cancer patient-caregiver dyads. J Psychosoc Oncol. 2017 Nov-Dec; 35(6):646-665.
    View in: PubMed
    Score: 0.010
  52. Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma. Head Neck. 2016 04; 38 Suppl 1:E1068-74.
    View in: PubMed
    Score: 0.009
  53. The Validity of Self-reported Recent Smoking in Head and Neck Cancer Surgical Patients. Otolaryngol Head Neck Surg. 2015 Dec; 153(6):990-995.
    View in: PubMed
    Score: 0.009
  54. Tobacco use and surgical outcomes in patients with head and neck cancer. Head Neck. 2016 May; 38(5):700-6.
    View in: PubMed
    Score: 0.009
  55. Lower circulating platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma. J Hematol Oncol. 2014 Sep 27; 7:65.
    View in: PubMed
    Score: 0.009
  56. Perioperative survival of elderly head and neck squamous cell carcinoma patients. Laryngoscope. 2014 Oct; 124(10):2281-6.
    View in: PubMed
    Score: 0.008
  57. Thyroid disease and compressive symptoms. Laryngoscope. 2012 Jan; 122(1):13-6.
    View in: PubMed
    Score: 0.007
  58. Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C18-ceramide as a novel biomarker for monitoring response. Clin Cancer Res. 2011 Sep 15; 17(18):6097-105.
    View in: PubMed
    Score: 0.007
  59. Neural outcomes after plasma knife dissection: a pathologic study and clinical correlation. Head Neck. 2010 Oct; 32(10):1321-7.
    View in: PubMed
    Score: 0.007
  60. Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma. Hum Immunol. 2010 Jul; 71(7):659-65.
    View in: PubMed
    Score: 0.006
  61. Respiratory-swallow phase patterns and their relationship to swallowing impairment in patients treated for oropharyngeal cancer. Head Neck. 2010 Apr; 32(4):481-9.
    View in: PubMed
    Score: 0.006
  62. Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer. Laryngoscope. 2010 Feb; 120(2):236-42.
    View in: PubMed
    Score: 0.006
  63. PET/CT in the assessment of previously treated skull base malignancies. Head Neck. 2010 Jan; 32(1):76-84.
    View in: PubMed
    Score: 0.006
  64. Effectiveness of calcium hydroxylapatite paste in vocal rehabilitation. Ann Otol Rhinol Laryngol. 2009 Aug; 118(8):546-51.
    View in: PubMed
    Score: 0.006
  65. Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers. Head Neck. 2009 Apr; 31(4):493-502.
    View in: PubMed
    Score: 0.006
  66. 1alpha,25-Dihydroxyvitamin D(3) to skew intratumoral levels of immune inhibitory CD34(+) progenitor cells into dendritic cells. Otolaryngol Head Neck Surg. 2009 Feb; 140(2):235-40.
    View in: PubMed
    Score: 0.006
  67. Human papillomavirus and head and neck cancer: a growing concern. J S C Med Assoc. 2008 Dec; 104(8):247-51.
    View in: PubMed
    Score: 0.006
  68. Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume. Int J Radiat Oncol Biol Phys. 2009 Apr 01; 73(5):1313-8.
    View in: PubMed
    Score: 0.006
  69. Effect of body mass index on chemoradiation outcomes in head and neck cancer. Laryngoscope. 2008 Jul; 118(7):1180-5.
    View in: PubMed
    Score: 0.006
  70. Proximal esophageal stenosis in head and neck cancer patients after total laryngectomy and radiation. ORL J Otorhinolaryngol Relat Spec. 2008; 70(4):229-35.
    View in: PubMed
    Score: 0.006
  71. Radiation dose, driving performance, and cognitive function in patients with head and neck cancer. Radiother Oncol. 2008 May; 87(2):304-7.
    View in: PubMed
    Score: 0.006
  72. Cranial neuropathy as a presenting sign of recurrent aggressive skin cancer. Dermatol Surg. 2008 Apr; 34(4):483-97.
    View in: PubMed
    Score: 0.005
  73. Driving performance in patients with cancer in the head and neck region: a pilot study. Arch Otolaryngol Head Neck Surg. 2007 Sep; 133(9):904-9.
    View in: PubMed
    Score: 0.005
  74. Driving behaviors in patients with head and neck cancer during and after cancer treatment: a preliminary report. Head Neck. 2007 Jul; 29(7):675-81.
    View in: PubMed
    Score: 0.005
  75. Role of mitomycin in upper digestive tract stricture. Head Neck. 2007 Jan; 29(1):12-7.
    View in: PubMed
    Score: 0.005
  76. Muscle-sparing abdominal free flaps in head and neck reconstruction. Head Neck. 2006 Sep; 28(9):802-7.
    View in: PubMed
    Score: 0.005
  77. Laryngeal penetration and aspiration during swallowing after the treatment of advanced oropharyngeal cancer. Arch Otolaryngol Head Neck Surg. 2005 Jul; 131(7):615-9.
    View in: PubMed
    Score: 0.005
  78. Swallowing-related quality of life after head and neck cancer treatment. Laryngoscope. 2004 Aug; 114(8):1362-7.
    View in: PubMed
    Score: 0.004
  79. Use of P-32 in stage III epithelial carcinoma of the ovary. Gynecol Oncol. 1994 Jul; 54(1):35-9.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.